Family · Pharmaceutical analytical standards
Fluphenazine
A high-potency typical antipsychotic of the phenothiazine family, approved in the United States in 1959: it blocks dopamine receptors and is used mainly for schizophrenia. This family brings together the active ingredient, pharmacopoeial impurities, metabolites, labelled standards, nitrosamines and other impurities.
Did you know?It also comes as an injectable decanoate ester: the medicine is released slowly, and a single injection works for about two weeks on average.
No product matches your search.
EDQM standards 5
The official European Pharmacopoeia standards for this family.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
